Shares of Arcutis Biotherapeutics, Inc. (ARQT) have traded between $19.32 – 27.73. The next earnings date is set for N/A. Let’s see how its prospects are shaping up.
What does Arcutis Biotherapeutics, Inc.(ARQT) do?
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.
ARQT Insider Trading Insight
On 2020-02-04, Bain Capital Life Sciences Investors, LLC 10% purchased 294,117 shares of ARQT. That represents a value of $3,979,292. Not to be outdone, on 2020-02-04, Heron Patrick J P – Purchase bought500,000 shares of ARQT. These insiders are clearly in the know because they work closely with the company.
UPS Intraday Trading
UPS is due to report earnings on Apr 23, 2020. In the last year the price has ranged from 92.66 – 125.31. Recently, Brothers Norman M. Jr sold 1,500 shares of UPS. He is a $174,641 shareholder in UPS.